Agilent 1100 Series Analysis of Therapeutic Peptides by HPLC Application Note

This document describes the features and characteristics of insulin, oxytocin, and angiotensin I, II, as well as their roles in blood sugar control, uterine contractions, and blood pressure regulation.


Agilent 1100 Series Analysis of Therapeutic Peptides by HPLC Application Note - cover page
Brand
Analysis
Category
Other
Document type
Application Note
Language
English
Pages
2
File format
PDF
File size
34 KB
Published
03 July, 2012
Updated
28 September, 2023
MD5 checksum
3C2411D063673784479881D09867DE05

About this manual

This document presents an HPLC method for the separation and analysis of therapeutic peptides, specifically insulin, angiotensin I, angiotensin II, and oxytocin. The method utilizes a reversed-phase column with UV detection and a gradient mobile phase to achieve reliable separation.

What's inside

  • Abstract
  • Conditions
  • Performance
  • Equipment
  • Columns

Specifications

ColumnZorbax SB-C18, 3.5 um, 4.6 x 75 mm
Flow rate1.0 ml/min
Column temperature25 °C
Injection volume5 ul
Autosampler temperature4°C

Frequently asked questions

What is the LOD for Oxytocin?

The Limit of Detection (LOD) for Oxytocin is 2.5 mg/l.

What is the recommended column for this analysis?

The recommended column is Zorbax SB-C18, 3.5 um, 4.6 x 75 mm.

Download PDF (34 KB)

More Analysis Manuals


View all Analysis manuals →